RxDoctor Payments Data

Shervin Mortazavi

Internal Medicine · Bronx, NYNPI 1740241850

Payments from drug & device makers

$373,562in general payments, 2019–2025

Across 466 payments — averaging $801.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$150K
  • AstraZeneca$97K
  • Otsuka America Pharmaceutical, Inc.$62K
  • Avanir Pharmaceuticals, Inc.$61K
  • Urovant Sciences Inc$3K
  • Lilly USA, LLC$503
  • plus $395 from 3 others

What the payments were for

  • Consulting fees$26,5937%
  • Speaking & faculty fees$308,69883%
  • Travel & lodging$24,2136%
  • Food & beverage$14,0584%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$373,562 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Other internal medicine in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →